A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2117166
PubMed Identifier: 36546625
Publication URI: http://europepmc.org/abstract/MED/36546625
Type: Journal Article/Review
Parent Publication: New England Journal of Medicine
Issue: 25
ISSN: 0028-4793